Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/105815
Title: Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents
Authors: Alves, Celso H. 
Serrano, Eurico 
Silva, Joana
Rodrigues, Carlos 
Pinteus, Susete
Gaspar, Helena 
Botana, Luis M.
Alpoim, Maria C. 
Pedrosa, Rui
Keywords: Marine natural products; Red seaweed; Lung cancer; Cancer stem cells; Microenvironment; Interleukin-6
Issue Date: Aug-2020
Publisher: Elsevier
Project: UID/MAR/04292/ 2020 
UID/Multi/04046/2020 
PTDC/ MAR-BIO/6149/2014 
POCI-01-0145- FEDER-016791 
Oncologia de Precisão: Terapias e Tecnologias Inovadoras project (POINT4PAC) (SAICTPAC/0019/2015 - LISBOA-01-0145-FEDER-016405) 
CROSS-ATLANTIC project (PTDC/BIA-OUT/29250/2017), co-financed by COMPETE (POCI- 01-0145-FEDER-029250) 
Integrated Programme of SR&TD "Smart Valorization of Endogenous Marine Biological Resources Under a Changing Climate" (reference Centro-01- 0145-FEDER-000018) 
SFRH/ BD/103255/2014 
metadata.degois.publication.title: Biomedicine and Pharmacotherapy
metadata.degois.publication.volume: 128
Abstract: Cancer is one of the major threats to human health and, due to distinct factors, it is expected that its incidence will increase in the next decades leading to an urgent need of new anticancer drugs development. Ongoing experimental and clinical observations propose that cancer cells with stem-like properties (CSCs) are involved on the development of lung cancer chemoresistance. As tumour growth and metastasis can be controlled by tumour-associated stromal cells, the main goal of this study was to access the antitumor potential of five bromoterpenes isolated from Sphaerococcus coronopifolius red alga to target CSCs originated in a co-culture system of fibroblast and lung malignant cells. Cytotoxicity of compounds (10-500 μM; 72 h) was evaluated on monocultures of several malignant and non-malignant cells lines (HBF, BEAS-2B, RenG2, SC-DRenG2) and the effects estimated by MTT assay. Co-cultures of non-malignant human bronchial fibroblasts (HBF) and malignant human bronchial epithelial cells (RenG2) were implemented and the compounds ability to selectively kill CSCs was evaluated by sphere forming assay. The interleucine-6 (IL-6) levels were also determined as cytokine is crucial for CSCs. Regarding the monocultures results bromosphaerol selectively eliminated the malignant cells. Both 12S-hydroxy-bromosphaerol and 12R-hydroxy-bromosphaerol steroisomers were cytotoxic towards non-malignant bronchial BEAS-2B cell line, IC50 of 4.29 and 4.30 μM respectively. However, none of the steroisomers induced damage in the HBFs. As to the co-cultures, 12R-hydroxy-bromosphaerol revealed the highest cytotoxicity and ability to abrogate the malignant stem cells; however its effects were IL-6 independent. The results presented here are the first evidence of the potential of these bromoterpenes to abrogate CSCs opening new research opportunities. The 12R-hydroxy-bromosphaerol revealed to be the most promising compound to be test in more complex living models.
URI: https://hdl.handle.net/10316/105815
ISSN: 07533322
DOI: 10.1016/j.biopha.2020.110275
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
1-s2.0-S0753332220304674-main.pdf2.58 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

10
checked on Jun 3, 2024

WEB OF SCIENCETM
Citations

10
checked on Jun 2, 2024

Page view(s)

101
checked on Oct 30, 2024

Download(s)

62
checked on Oct 30, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons